Quiet Day in Life Science Stocks After a Strong Start in 2013
Healthcare Sector Gets Boost from JPMorgan Conference-Large Caps Lag Except CELG Most life science stocks were quiet today after a strong showing during the JPMorgan Healthcare Conference Jan. 7-10. The biotechnology sector was up over 35% in 2012 and usually this trend is carried through...
2012 Performance-Rayno Life Sciences Diagnostics and Tools: ILMN, NEOG, QDEL
Rayno Diagnostics and Tools -Another Year of Outstanding Performance In a volatile year with a few earnings disappointments and the summer doldrums, the sector did quite well due to synergies with new drug therapies, technological innovation such as genomics and biomarkers, sales growth from...
Global “Risk-On” Rally Across Most Sectors Especially Biotechnology
The Bi-Partisan Cliff Deal Nobody Likes (Except the Market) Investors like the tax deal as it is favorable to investors despite the tax increases. Stocks are holding their gains after a "mini-fiscal" cliff deal that drove the Dow and S&P up 1.7% and NASDAQ up 2.4%. Life science stocks...
Rayno Biopharmaceutical Focus Stocks YTD: Top Performers include AMRI,GILD, REGN
Outstanding Year for Biotechnology -Average Performance is up 35% YTD Many Rayno Life Science Stocks have outperformed the sector and the ETFs: Albany Molecular Inc. (AMRI), a contract research organization with long term experience in drug discovery, development and manufacturing soared 82%...
Life Science Stocks Brought Down by Dysfunctional Congress
End of Year Rally Crushed By Turmoil in Budget Talks Up until late yesterday investors were optimistic about a budget deal with the "Kubuki Theater" Congress. You have heard enough about the fiscal cliff and non-starter proposals to avert the fiscal cliff so let this link suffice. Up until now...